Patients with antibody deficiencies demonstrated reduced immunogenicity following vaccination against the SARS-CoV-2 virus, according to a study published in Journal of Clinical Immunology.
These findings demonstrate the ongoing risk that the virus presents these patients, Adrian M. Shields, MBBS, MRCP, PhD, clinical lecturer at University of Birmingham Institute of Immunology and Immunotherapy in the United Kingdom, and colleagues wrote.
Read more in Healio.